Skip to search formSkip to main contentSkip to account menu

Carnitine palmitoyl transferase 2 deficiency

Known as: CPT-II, CPT II Deficiency, Carnitine Palmitoyltransferase II Deficiency 
A rare, autosomal recessive inherited disorder of long-chain fatty-acid oxidation caused by mutations in the CPT2 gene. The disease includes three… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
There is growing evidence that mitochondrial dysfunction, and more specifically fatty acid β-oxidation impairment, is involved in… 
Highly Cited
2005
Highly Cited
2005
The rate of cardiac fatty acid oxidation is regulated by the activity of carnitine palmitoyltransferase-I (CPT-I), which is… 
Highly Cited
2005
Highly Cited
2005
Patients with the myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency typically experience muscle pain… 
2003
2003
Peroxisome proliferator-activated receptors (PPARs) are key regulators of macrophage lipid metabolism. We compared the effects of… 
Highly Cited
2001
Highly Cited
2001
Liver carnitine palmitoyltransferase I (L-CPT I) catalyses the transfer of long-chain fatty acid (LCFA) for translocation across… 
2000
Highly Cited
2000
Highly Cited
2000
Male weanling Wistar rats (n=15), weighing 200–220 g, were allocated for 6 wk to diets containing 1% (by weight) of conjugated… 
Highly Cited
1998
Highly Cited
1998
Salmon farmers are currently using high-energy feeds containing up to 35% fat; the fish's capability of fully utilizing these… 
Highly Cited
1997
Highly Cited
1997
Incubation of rat hepatocytes with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), an activator of the 5'-AMP-activated…